Q3 2024 · 13F-HR
Rhenman & Partners Asset Management ABholdings as filed
Filed 2024-11-13 · accession 0001213900-24-097092
$1.23B
Reported value
95
Positions
2024-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 101137107 | BSX | BOSTON SCIENTIFIC CORP | $49.4M | 4.01% | 590,000 | Common | SOLE |
| 91324P102 | UNH | UNITED HEALTH GROUP INC | $42.5M | 3.45% | 72,700 | Common | SOLE |
| 532457108 | LLY | LILLY ELI & CO | $42.1M | 3.42% | 47,500 | Common | SOLE |
| 75886F107 | REGN | REGENERON PHARMACEUTICALS | $41.0M | 3.33% | 39,000 | Common | SOLE |
| 88033G407 | THC | TENET HEALTHCARE CORP | $36.8M | 2.99% | 221,400 | Common | SOLE |
| 74276L105 | PRCT | PROCEPT BIOROBOTICS CORP | $35.7M | 2.89% | 445,000 | Common | SOLE |
| 00287Y109 | ABBV | ABBVIE INC | $35.0M | 2.84% | 177,000 | Common | SOLE |
| G5960L103 | MDT | MEDTRONIC PLC | $33.1M | 2.69% | 368,000 | Common | SOLE |
| 30063P105 | EXK | EXACT SCIENCES CORP | $31.7M | 2.57% | 465,000 | Common | SOLE |
| 40412C101 | HCA | HCA HEALTHCARE INC | $31.0M | 2.51% | 76,229 | Common | SOLE |
| 46120E602 | ISRG | INTUITIVE SURGICAL INC | $31.0M | 2.51% | 63,000 | Common | SOLE |
| 375558103 | GILD | GILEAD SCIENCES INC | $30.7M | 2.49% | 366,500 | Common | SOLE |
| 632307104 | NTRA | NATERA INC | $29.3M | 2.38% | 231,000 | Common | SOLE |
| 687793109 | OSCR | OSCAR HEALTH INC | $29.1M | 2.36% | 1,371,147 | Common | SOLE |
| 58933Y105 | MRK | MERCK & CO. INC | $27.4M | 2.22% | 241,000 | Common | SOLE |
| 075887109 | BDX | BECTON DICKINSON & CO | $27.1M | 2.20% | 112,500 | Common | SOLE |
| 036752103 | ELV | ELEVANCE HEALTH INC | $26.3M | 2.13% | 50,500 | Common | SOLE |
| 457730109 | INSP | INSPIRE MED SYS INC | $25.7M | 2.09% | 122,000 | Common | SOLE |
| 09061G101 | BMRN | BIOMARIN PHARMACEUTICAL INC | $25.6M | 2.08% | 364,500 | Common | SOLE |
| 216648501 | COO | COOPER COS INC | $25.2M | 2.04% | 228,000 | Common | SOLE |
| 01625V104 | ALHC | ALIGNMENT HEALTHCARE INC | $23.4M | 1.90% | 1,977,363 | Common | SOLE |
| 235851102 | DHR | DANAHER CORPORATION | $23.2M | 1.88% | 83,302 | Common | SOLE |
| 92532F100 | VRTX | VERTEX PHARMACEUTICALS INC | $22.2M | 1.80% | 47,750 | Common | SOLE |
| G7709Q104 | RPRX | ROYALTY PHARMA PLC | $17.4M | 1.41% | 613,500 | Common | SOLE |
| 883556102 | TMO | THERMO FISHER SCIENTIFIC INC | $15.5M | 1.26% | 25,100 | Common | SOLE |
| 002824100 | ABT | ABBOTT LABS | $15.4M | 1.25% | 135,000 | Common | SOLE |
| 46116X101 | ITCIEUR | INTRA-CELLULAR THERAPIES INC | $15.0M | 1.22% | 205,500 | Common | SOLE |
| 58155Q103 | MCK | MCKESSON CORP | $14.9M | 1.21% | 30,117 | Common | SOLE |
| 377322102 | GKOS | GLAUKOS CORP | $14.5M | 1.17% | 111,000 | Common | SOLE |
| 125523100 | CI | THE CIGNA GROUP | $14.4M | 1.17% | 41,685 | Common | SOLE |
| 016255101 | ALGN | ALIGN TECHNOLOGY INC | $14.0M | 1.14% | 55,000 | Common | SOLE |
| 02043Q107 | ALNY | ALNYLAM PHARMACEUTICALS INC | $13.8M | 1.12% | 50,350 | Common | SOLE |
| 268158201 | DVAX | DYNAVAX TECHNOLOGIES CORP | $13.3M | 1.08% | 1,190,000 | Common | SOLE |
| 09062X103 | BIIB | BIOGEN INC | $13.0M | 1.06% | 67,100 | Common | SOLE |
| 670100205 | NVO | NOVO-NORDISK A S | $11.9M | 0.97% | 100,000 | Common | SOLE |
| 126650100 | CVS | CVS HEALTH CORP | $11.6M | 0.94% | 184,000 | Common | SOLE |
| 46266C105 | IQV | IQVIA HLDGS INC | $11.4M | 0.92% | 48,000 | Common | SOLE |
| 05464T104 | AXSM | AXSOME THERAPEUTICS INC | $11.0M | 0.89% | 122,600 | Common | SOLE |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $10.6M | 0.86% | 367,500 | Common | SOLE |
| G50871105 | JAZZ | JAZZ PHARMACEUTICALS PLC | $10.4M | 0.84% | 93,000 | Common | SOLE |
| 60855R100 | MOH | MOLINA HEALTHCARE INC | $10.2M | 0.83% | 29,600 | Common | SOLE |
| 03073E105 | COR | CENCORA INC | $10.2M | 0.82% | 45,150 | Common | SOLE |
| 462260100 | IOVA | IOVANCE BIOTHERAPEUTICS INC | $9.9M | 0.80% | 1,052,500 | Common | SOLE |
| 444859102 | HUM | HUMANA INC | $9.8M | 0.80% | 31,000 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $9.5M | 0.77% | 180,500 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $9.5M | 0.77% | 129,513 | Common | SOLE |
| 45784P101 | PODD | INSULET CORP | $9.3M | 0.76% | 40,000 | Common | SOLE |
| 670703107 | NUVL | NUVALENT INC | $9.2M | 0.75% | 90,000 | Common | SOLE |
| 15135B101 | CNC | CENTENE CORP DEL | $8.8M | 0.71% | 116,982 | Common | SOLE |
| 863667101 | SYK | STRYKER CORPORATION | $8.3M | 0.67% | 23,000 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $8.3M | 0.67% | 71,750 | Common | SOLE |
| 462222100 | IONS | IONIS PHARMACEUTICALS INC | $7.8M | 0.63% | 195,000 | Common | SOLE |
| 30050B101 | EVH | EVOLENT HEALTH INC | $7.5M | 0.61% | 265,000 | Common | SOLE |
| 159864107 | CRL | CHARLES RIV LABS INTL INC | $7.4M | 0.60% | 37,500 | Common | SOLE |
| 89377M109 | TMDX | TRANSMEDICS GROUP INC | $7.1M | 0.58% | 45,270 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $6.9M | 0.56% | 243,000 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $6.8M | 0.55% | 268,000 | Common | SOLE |
| 67080M103 | NRIX | NURIX THERAPEUTICS INC | $6.7M | 0.55% | 300,000 | Common | SOLE |
| 00404A109 | ACHC | ACADIA HEALTHCARE COMPANY INC | $6.7M | 0.54% | 105,750 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $6.5M | 0.53% | 102,500 | Common | SOLE |
| 09075V102 | BNTX | BIONTECH SE | $6.1M | 0.49% | 51,000 | Common | SOLE |
| 29261A100 | EHC | ENCOMPASS HEALTH CORP | $5.9M | 0.48% | 61,000 | Common | SOLE |
| 252131107 | DXCM | DEXCOM INC | $5.8M | 0.47% | 87,000 | Common | SOLE |
| 87164F105 | SNDX | SYNDAX PHARMACEUTICALS INC | $5.0M | 0.41% | 259,500 | Common | SOLE |
| 29668H708 | EPIEUR | ESSA PHARMA INC | $4.9M | 0.40% | 804,649 | Common | SOLE |
| 47103J105 | JANX | JANUX THERAPEUTICS INC | $4.9M | 0.39% | 106,847 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $4.5M | 0.37% | 1,000,000 | Common | SOLE |
| 252828108 | DNTH | DIANTHUS THERAPEUTICS INC | $4.1M | 0.33% | 150,000 | Common | SOLE |
| 98401F105 | XNCR | XENCOR INC | $4.1M | 0.33% | 203,750 | Common | SOLE |
| 604749101 | MIRM | MIRUM PHARMACEUTICALS INC | $4.1M | 0.33% | 105,000 | Common | SOLE |
| 45166A102 | IDYA | IDEAYA BIOSCIENCES INC | $4.0M | 0.33% | 127,500 | Common | SOLE |
| 88322Q108 | TGTX | TG THERAPEUTICS INC | $4.0M | 0.33% | 171,500 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $4.0M | 0.32% | 79,500 | Common | SOLE |
| G01767105 | ALKS | ALKERMES PLC | $3.7M | 0.30% | 133,000 | Common | SOLE |
| 03589W102 | ANNX | ANNEXON INC | $3.3M | 0.27% | 560,000 | Common | SOLE |
| 29664W105 | ESPR | ESPERION THERAPEUTICS INC NE | $3.3M | 0.26% | 1,975,000 | Common | SOLE |
| 75943R102 | RLAY | RELAY THERAPEUTICS INC | $3.3M | 0.26% | 460,000 | Common | SOLE |
| 50127T109 | KURA | KURA ONCOLOGY IN | $3.3M | 0.26% | 166,526 | Common | SOLE |
| 558868105 | MDGL | MADRIGAL PHARMACEUTICALS INC | $3.2M | 0.26% | 15,300 | Common | SOLE |
| 04335A105 | ARVN | ARVINAS INC | $3.2M | 0.26% | 130,500 | Common | SOLE |
| 501147102 | KRYS | KRYSTAL BIOTECH INC | $3.1M | 0.25% | 17,000 | Common | SOLE |
| 449585108 | 1K0 | IGM BIOSCIENCES INC | $3.1M | 0.25% | 185,459 | Common | SOLE |
| 116794108 | BRKR | BRUKER CORP | $3.1M | 0.25% | 44,315 | Common | SOLE |
| 03940C100 | ACLXGBX | ARCELLX INC | $2.7M | 0.22% | 32,000 | Common | SOLE |
| 58506Q109 | MEDP | MEDPACE HLDGS INC | $2.5M | 0.20% | 7,500 | Common | SOLE |
| 913903100 | UHS | UNIVERSAL HLTH SVCS INC | $1.8M | 0.15% | 8,000 | Common | SOLE |
| 45258D105 | IMCR | IMMUNOCORE HLDGS PLC | $1.8M | 0.15% | 58,278 | Common | SOLE |
| 74276R102 | PRVA | PRIVIA HEALTH GROUP INC | $1.7M | 0.14% | 95,189 | Common | SOLE |
| 09073M104 | TECH | BIO-TECHNE CORP | $1.6M | 0.13% | 20,000 | Common | SOLE |
| 759916109 | RGEN | REPLIGEN CORP | $1.5M | 0.12% | 10,000 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $1.4M | 0.11% | 35,000 | Common | SOLE |
| 729139105 | PLRX | PLIANT THERAPEUTICS INC | $1.3M | 0.11% | 120,250 | Common | SOLE |
| 05352A100 | AVTR | AVANTOR INC | $1.1M | 0.09% | 44,000 | Common | SOLE |
| 031162100 | AMGN | AMGEN INC | $966,630 | 0.08% | 3,000 | Common | SOLE |
| 45782T105 | INMB | INMUNE BIO INC | $960,951 | 0.08% | 178,284 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.